BioRender 图标

Collection tube (2mL 1/4 liquid)

Collection tube (2mL 1/4 liquid) - Editable icon of a 2ml collection tube filled with 1/4 liquid

[{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a6db9305a0c/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a6db9305a0c/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3ad7ad305a0b/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3ad7ad305a0b/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a854e305a0a/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a854e305a0a/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a2871305a09/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a2871305a09/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a22e4305a08/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a22e4305a08/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a008d305a07/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a008d305a07/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a1d5b305a06/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a1d5b305a06/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a704b305a05/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a704b305a05/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3afdc3305a04/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3afdc3305a04/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3aa6ad305a03/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3aa6ad305a03/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a01bb305a02/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a01bb305a02/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a20cf305a01/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a20cf305a01/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a5d2a305a00/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a5d2a305a00/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a22783059ff/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a22783059ff/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a43823059fe/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a43823059fe/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a6d943059fd/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a6d943059fd/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a29e83059fc/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a29e83059fc/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a2fe33059fb/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a2fe33059fb/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a04943059fa/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a04943059fa/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a36b63059f9/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a36b63059f9/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3af6083059f8/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3af6083059f8/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a0b5d3059f7/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a0b5d3059f7/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a62493059f6/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a62493059f6/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3acef03059f5/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3acef03059f5/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a5ec63059f4/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a5ec63059f4/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a695c3059f3/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a695c3059f3/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a78333059f2/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a78333059f2/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a684c3059f1/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a684c3059f1/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3aca5f3059f0/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3aca5f3059f0/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3aa7523059ef/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3aa7523059ef/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a25aa3059ee/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a25aa3059ee/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a1c503059ed/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a1c503059ed/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3ab0d93059ec/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3ab0d93059ec/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3afed93059eb/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3afed93059eb/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a7a093059ea/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a7a093059ea/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3afd9b3059e9/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3afd9b3059e9/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3adaba3059e8/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3adaba3059e8/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a8cc53059e7/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a8cc53059e7/661d3a3ab5bc3a0ca53059e5.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/661d3ac3b5bc3a548b3059e6/661d3a3ab5bc3a0ca53059e5.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/661d3ac3b5bc3a548b3059e6/661d3a3ab5bc3a0ca53059e5.png"}]

使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍
page dashboard

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right

collection,tube,protein,purification,column,spin,micro,centrifuge,open,acid,DNA,RNA,plasmid,2mL,tube,full,liquid,filled,falcon tube,test tube,culture tube,sample tube,culture,sample,test,falcon,laboratory,experiment,silica,membrane,compression ring,filter,liquid,separate,collection tube,yield,isolation,plastic,chromatography,gravity,separation,binding,matrix,resin,affinity,ion exchange,size exclusion,selectivity,elution,biomolecules,peptides,measurement,measure,measuring,holding,containing,contain,collect,collecting,sample,chemical reaction,mixing,heating,cooling,dissolving,precipitation,boiling,distillation,analysis,sample preparation,analytical chemistry,biotechnology,front,front view,anterior,frontal,anterior view

查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Collection tube (2mL 1/4 liquid) icon JPEG

Collection tube (2mL 1/4 liquid) icon PNG

Collection tube (2mL 1/4 liquid) icon SVG

Collection tube (2mL 1/4 liquid) icon GIF

BioRender 图标常见问题解答

How are scientists using the Collection tube (2mL 1/4 liquid) icon in their work?

BioRender users often use the Collection tube (2mL 1/4 liquid) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Lab and Objects.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Collection tube (2mL 1/4 liquid) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Collection tube (2mL 1/4 liquid) icon customizable in BioRender?

Most icons in BioRender, including the Collection tube (2mL 1/4 liquid) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Collection tube (2mL 1/4 liquid) icon for publication or presentations?

Yes, figures containing the Collection tube (2mL 1/4 liquid) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Collection tube (2mL 1/4 liquid) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Collection tube (2mL 1/4 liquid) icon — especially those focused on Lab and Objects. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Collection tube (2mL 1/4 liquid) icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon